Moleculin Biotech (MBRX) Releases Earnings Results, Misses Expectations By $0.06 EPS

Moleculin Biotech (MBRX) Releases Earnings Results, Misses Expectations By $0.06 EPS

Moleculin Biotech issued its earnings results on Monday. The company reported earnings per share for the quarter, missing the Zacks' consensus estimate of by , MarketWatch Earnings reports.

from Biotech News